Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-CA-20-001

U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trials Optional)

Closed on January 10, 2020.

Posted
October 17, 2019
Close date
January 10, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
7
7 new
Median first-year cost
$1,038,176
$7,466,093 in all
Institutions
7
7 contact PIs
Patents
5
from 1 funded project

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. ALBERT EINSTEIN COLLEGE OF MEDICINE1
  2. BAYLOR COLLEGE OF MEDICINE1
  3. CASE WESTERN RESERVE UNIVERSITY1
  4. INDIANA UNIVERSITY INDIANAPOLIS1
  5. JOHNS HOPKINS UNIVERSITY1

and 2 other institutions

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 TCRB-D (M1))7
7 awards under RFA-CA-20-001 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2020Pediatric HIV/AIDS & Infection-Related Malignancies Research Consortium for sub-Saharan Africa (PARCA)1U54CA254569-01Allen, Carl EJoloba, Moses LutaakomeScheurer, Michael E.BAYLOR COLLEGE OF MEDICINE, TXFirst-year cost $1,185,076Study section ZCA1
FY2020Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa1U54CA254564-01Chibwesha, Carla JDamania, Blossom ADittmer, Dirk PFedoriw, YuriRuff, PaulTweya, Hannock MukomaUNIV OF NORTH CAROLINA CHAPEL HILL, NCFirst-year cost $1,180,460Study section ZCA1
FY2020United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers1U54CA254571-01Kambugu, Andrew DdunguMartin, Jeffrey NUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CAFirst-year cost $1,054,123Study section ZCA1
FY2020HIV and HCC in Africa: The H2A Consortium1U54CA254565-01Kirk, Gregory DOcama, PonsianoJOHNS HOPKINS UNIVERSITY, MDFirst-year cost $1,038,176Study section ZCA1
FY2020Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging1U54CA254566-01Gerson, Stanton L.Kirenga, Bruce JamesMfinanga, Godfrey SayokiSalata, Robert ACASE WESTERN RESERVE UNIVERSITY, OHFirst-year cost $1,024,684Study section ZCA1
FY2020The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS1U54CA254518-01Brown, Darron RLoehrer, Patrick J.Nakalembe, MiriamOrango, Elkanah OmengeINDIANA UNIVERSITY INDIANAPOLIS, INFirst-year cost $995,284Study section ZCA1
FY2020Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies1U54CA254568-01Adedimeji, AdebolaAnastos, Kathryn M.Mutesa, LeonYotebieng, MarcelALBERT EINSTEIN COLLEGE OF MEDICINE, NYFirst-year cost $988,290Study section ZCA1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

5 patents name 1 of the 7 funded projects.

  1. US 12,755,841 (opens the patent at USPTO, a PDF, in a new tab)MULTI-SITE CROSS-ORGAN CALIBRATED DEEP LEARNING (MUSCID) METHOD AND APPARATUSGranted October 6, 2026 to Case Western Reserve University, Emory University and 2 othersU54CA254566 · CASE WESTERN RESERVE UNIVERSITY, OH
  2. US 12,530,770 (opens the patent at USPTO, a PDF, in a new tab)DEEP-LEARNING-BASED HEPATIC FAT ASSESSMENTGranted January 20, 2026 to Case Western Reserve University, Emory University and University Hospitals Cleveland Medical CenterU54CA254566 · CASE WESTERN RESERVE UNIVERSITY, OH
  3. US 12,159,403 (opens the patent at USPTO, a PDF, in a new tab)COMBINATION OF FEATURES FROM BIOPSIES AND SCANS TO PREDICT PROGNOSIS IN SCLCGranted December 3, 2024 to The United States Government as Represented by the Department of Veteran AffairsU54CA254566 · CASE WESTERN RESERVE UNIVERSITY, OH
  4. US 12,073,560 (opens the patent at USPTO, a PDF, in a new tab)COMPUTATIONAL FEATURES OF TUMOR-INFILTRATING LYMPHOCYTE (TIL) ARCHITECTUREGranted August 27, 2024 to University of Pittsburgh—Of the Commonwealth System of Higher EducationU54CA254566 · CASE WESTERN RESERVE UNIVERSITY, OH
  5. US 12,037,560 (opens the patent at USPTO, a PDF, in a new tab)COMPUTATIONAL FEATURES OF TUMOR-INFILTRATING LYMPHOCYTE (TIL) ARCHITECTUREGranted July 16, 2024 to BIOCOAT, INCORPORATEDU54CA254566 · CASE WESTERN RESERVE UNIVERSITY, OH

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-22-0.3.11. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-CA-20-001: U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trials Optional) | ConductScience ScienceDex